Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.57 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.50 |
| ▸ | CPB2 | Q96IY4 | 5/20 | 0.46 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.45 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.44 |
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.38 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.38 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | PLG | P00747 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5323156 | 0.98 | GSR (0.55) | GSRRNPEPCPB2GABRR1SLC7A5 | |
| SCHEMBL2420748 | 0.94 | GSR (0.48) | GSRRNPEPCPB2GABRR1SLC7A5 | |
| SCHEMBL2420751 | 0.94 | GSR (0.48) | GSRRNPEPCPB2GABRR1SLC7A5 | |
| SCHEMBL8015462 | 0.94 | GSR (0.48) | GSRRNPEPCPB2GABRR1SLC7A5 | |
| SCHEMBL2330401 | 0.85 | GABRR1 (0.56) | GSRRNPEPGABRR1SLC7A5 | |
| SCHEMBL2424605 | 0.85 | GABRR1 (0.56) | GSRRNPEPGABRR1SLC7A5 | |
| SCHEMBL8018052 | 0.85 | GABRR1 (0.56) | GSRRNPEPGABRR1SLC7A5 | |
| SCHEMBL2324416 | 0.85 | GABRR1 (0.56) | GSRRNPEPGABRR1SLC7A5 | |
| SCHEMBL3515974 | 0.85 | GABRR1 (0.56) | GSRRNPEPGABRR1SLC7A5 | |
| SCHEMBL2334387 | 0.85 | GABRR1 (0.56) | GSRRNPEPGABRR1SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070258899-A1 | Diagnostic and therapeutic agents | KARYON-CTT LTD (FI) | 2007-11-08 | — | — | US | disclosed |
| WO-2007113385-A1 | DIAGNOSTIC AND THERAPEUTIC AGENTS | KARYON-CTT LTD (FI) | 2007-10-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070258899-A1 | Diagnostic and therapeutic agents | YBX1, MLX, TPX2 | GSR 2317/4885RNPEP 1802/4885CPB2 3185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.